Antibiotic prescribing for children in primary care and adherence to treatment guidelines

Verica Ivanovska1, Karin Hek2, Aukje K Mantel Teeuwisse3

  • 1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands vericaivanovska@hotmail.com.

Insights

Antibiotic prescribing for pediatric respiratory tract infections (RTIs) in the Netherlands remains high, with significant variation between practices. Guidelines are not consistently followed, particularly for acute bronchitis.

Area of Science:

  • General Practice
  • Pediatric Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic use for pediatric respiratory tract infections (RTIs) in primary care is often unnecessarily high.
  • Implementing treatment guidelines for RTIs in children presents practical challenges.

Purpose of the Study:

  • To assess adherence to antibiotic prescribing guidelines for pediatric RTIs in Dutch primary care.
  • To examine variations in guideline adherence across different general practices.

Main Methods:

  • Retrospective observational study using the NIVEL Primary Care Database (2010-2012).
  • Included patients under 18 with fever, ear, or respiratory infections.
  • Assessed guideline adherence using disease-specific outcomes and multilevel analysis for inter-practice variability.

Main Results:

  • Antibiotics were used in 50% of RTIs with restrictive policies and 65% of pneumonia cases.
  • 40% of acute bronchitis episodes received antibiotics, contrary to guidelines.
  • Adherence to guidelines varied significantly across diagnoses and practices, with lowest use of narrow-spectrum penicillins.

Conclusions:

  • Paediatric RTIs in the Netherlands are frequently treated conservatively with antibiotics.
  • Inappropriate antibiotic prescribing for acute bronchitis and underuse of some first-choice antibiotics are concerns.
  • Targeting practices with lower adherence rates can improve guideline implementation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
693
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
25
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
393
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
458